Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
8.58
-0.07 (-0.81%)
At close: May 12, 2025, 4:00 PM
8.58
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
Company Description
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.
Jade Biosciences, Inc.
| Country | United States |
| Founded | 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Tom Frohlich |
Contact Details
Address: 221 Crescent Street Building 23, Suite 105 Waltham, Massachusetts 02453 United States | |
| Phone | 916 322 1700 |
| Website | jadebiosciences.com |
Stock Details
| Ticker Symbol | JBIO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000947559 |
| CUSIP Number | 008064206 |
| ISIN Number | US0080642061 |
Key Executives
| Name | Position |
|---|---|
| Tom Frohlich | Chief Executive Officer |
| Jonathan Quick | Chief Financial Officer |